Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK , the Financial Times reported on ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

President Donald Trump met Friday with Nvidia CEO Jensen Huang, marking the first meeting between the president and the leader of a chip company at the center of the artificial intelligence gold ...

Kim, 54, has been running Takeda’s US operations since 2022and will assume the role of CEO in June next year, subject to shareholder approval, the company said in a statement Wednesday.

Prior to joining the Japanese pharma giant, Weber worked at GSK for more than two decades, leaving in March 2014 as president and GM of vaccines. Since assuming the CEO post in 2015, Weber has guided ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Not by a little bit, by a lot," BofA Chairman and CEO Brian Moynihan said of America’s economic landscape during a "Mornings with Maria" interview from the World Economic Forum in Davos ...

Ontario Liberal MPP Adil Shamji said removing the Ontario Health atHome CEO was “long past due” but failed to address a deeper problem. “Home care should be the focus — not the footnote ...

According to the email, while the company looks for its next CEO, Stacie Herron, KE’s current chief legal and administrative officer will serve as interim chief operating officer. In a statement ...